BCR and acute lymphoblastic leukemia: No significant difference was found in the BCR/ABL mRNA levels between the LPCs and other cell fractions from the patients with de novo Ph+ALL as measured by qRT-PCR (Fig. 2c, 1.07 ± 0.17-fold, P > 0.99).